Platelet-rich plasma (PRP) therapy: Some emerging evidence exists, but PRP is not currently recommended by NICE and NHS availability is variable
Acknowledgements We thank Lucy Ghoda and Gerardo Felix for assistance with blood cone collection, and the participants in our repository protocols for supporting translational research
The results were significant: At 48 weeks, participants receiving the 12 mg dose achieved a mean weight reduction of 24.2% (approximately 58 pounds or 26.2 kg) 100% of participants on the 8 mg or 12 mg doses lost at least 5% of their body weight More than 90% of participants on the 12 mg dose lost at least 10% of their body weight Nearly half of participants on the highest dose lost 25% or more of their body weight The study also showed improvements in cardiometabolic markers including blood pressure, triglycerides, LDL cholesterol, and fasting glucose
Boosting D3 levels may help mitigate the symptoms of SAD, such as low mood, irritability, and lack of energy
Latroche, C
Over 4,000 genes are shifting toward regenerative expression patterns